LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference
LFSTSCOTTSDALE, Ariz., Aug. 26, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 23rd Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY.
Sarah Personette Appointed to LifeStance Board of Directors
LFSTDirector William Miller to Step Down SCOTTSDALE, Ariz., Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media...
LifeStance Reports Second Quarter 2025 Results
LFSTSCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2025.
UBS Upgrades LifeStance Health Gr to Buy, Announces $8.5 Price Target
LFSTLifeStance Health Gr Sees Q2 Sales $332.000M-$352.000M vs $352.76M Est
LFSTLifeStance Health Gr Affirms FY2025 Sales Guidance of $1.40B-$1.44B vs $1.42B Est
LFSTLifeStance Health Gr Q1 Sales $332.97M Beat $332.90M Estimate
LFSTKeybanc Initiates Coverage On LifeStance Health Gr with Overweight Rating, Announces Price Target of $9
LFSTCanaccord Genuity Initiates Coverage On LifeStance Health Gr with Buy Rating, Announces Price Target of $8
LFSTLifeStance Expects 2025 Revenue Of $1.40B - $1.44B, Est $1.391B; $320M - $340M For Q1 (Est $339.634M)
LFSTLifeStance Health Gr Q4 2024 GAAP EPS $(0.01) Beats $(0.04) Estimate, Sales $325.50M Beat $313.72M Estimate
LFSTLifeStance Names Dave Bourdon As CEO; Ken Burdick Named As Executive Chairman
LFSTLifeStance Health Gr Option Alert: Mar 21 $8 Calls At The Ask: 4825 @ $0.3 vs 2317 OI; Earnings 2/27 Before Open Ref=$7.515
LFSTWhy Lifestance Health Group (LSFT) Stock Is Falling
LFSTLifeStance Health shares are trading lower by 19.8% during Wednesday's session. The company announced pricing of a 20 million share offering by selling stockholders.
Reported Earlier, LifeStance Health Group Prices Secondary Public Offering Of 20M Common Shares At $6.25/Share
LFSTLifeStance Health Group Announces Launch Of 20M Share Offering By Selling Shareholders
LFSTLifeStance Health Appoints Ken Burdick As CEO And Chairman; Founding CEO And Chairman Michael Lester Retires; Danish Qureshi Named President In Addition To Role As COO
LFST